Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HRS-2329 Combinations in Advanced Pancreatic Cancer
NCT07736612Phase 2Not yet recruiting
- Sponsor
- Zhejiang University
- Start
- Aug 2026
- Primary completion
- Aug 2028
- Countries
- 1
01
Overview
A Phase 2 trial of HRS-2329 in pancreatic cancer (PC), sponsored by Zhejiang University. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
HRS-2329
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT07736612.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07736612.